Primary |
Multiple Sclerosis |
71.4% |
Back Pain |
28.6% |
|
Transaminases Increased |
66.7% |
Throat Cancer |
33.3% |
|
Secondary |
Drug Use For Unknown Indication |
27.9% |
Pain |
16.3% |
Gastrooesophageal Reflux Disease |
9.3% |
Back Pain |
7.0% |
Dyspepsia |
7.0% |
Blood Pressure |
4.7% |
Hypothyroidism |
4.7% |
Multiple Sclerosis |
4.7% |
Product Used For Unknown Indication |
4.7% |
Smoking Cessation Therapy |
4.7% |
Antibiotic Therapy |
2.3% |
Mood Altered |
2.3% |
Nephrolithiasis |
2.3% |
Rheumatoid Arthritis |
2.3% |
|
Drug Hypersensitivity |
61.3% |
Intentional Overdose |
6.5% |
Nausea |
6.5% |
Rash Erythematous |
6.5% |
Chromaturia |
3.2% |
Pruritus |
3.2% |
Respiratory Rate Decreased |
3.2% |
Rib Fracture |
3.2% |
Speech Disorder |
3.2% |
Vomiting |
3.2% |
|
Concomitant |
Abdominal Pain |
11.6% |
Gastrooesophageal Reflux Disease |
10.9% |
Product Used For Unknown Indication |
10.6% |
Pain |
9.3% |
Nausea |
7.4% |
Hypertension |
4.4% |
Anxiety |
4.0% |
Bipolar Disorder |
3.5% |
Constipation |
3.5% |
Electrolyte Substitution Therapy |
3.5% |
Fungal Infection |
3.5% |
Hypercholesterolaemia |
3.5% |
Hypothyroidism |
3.5% |
Multiple Allergies |
3.5% |
Pyrexia |
3.5% |
Tremor |
3.5% |
Drug Use For Unknown Indication |
2.9% |
Insomnia |
2.7% |
Impaired Gastric Emptying |
2.3% |
Oropharyngeal Pain |
2.3% |
|
Suicide Attempt |
38.6% |
Vomiting |
9.1% |
Vitreous Floaters |
5.7% |
Weight Increased |
4.5% |
Headache |
3.4% |
Intraocular Pressure Increased |
3.4% |
Pain |
3.4% |
Pulmonary Embolism |
3.4% |
Thrombosis |
3.4% |
Urethral Injury |
3.4% |
Dysgeusia |
2.3% |
Lymphocyte Count Decreased |
2.3% |
Myocardial Infarction |
2.3% |
Pulmonary Hypertension |
2.3% |
Rash |
2.3% |
Sleep Disorder |
2.3% |
Tremor |
2.3% |
Vulvovaginal Pain |
2.3% |
Weight Decreased |
2.3% |
Anxiety |
1.1% |
|